Table 5 Side effects from methotrexate treatmentaa

From: Low-risk persistent gestational trophoblastic disease treated with low-dose methotrexate: efficacy, acute and long-term effects

 

First course of treatment

Subsequent courses

Side effect

Grade I/II

Grade III/IV

Grade I/II

Grade III/IV

Anaemia

  

2 (0.8%)

 

Neutropenia

 

1 (0.4%)

1 (0.4%)

2 (0.8%)

Thrombocytopenia

 

1 (0.4%)

1 (0.4%)

1 (0.4%)

Nausea

19 (7.6%)

 

37 (14.8)

 

Vomiting

5 (2%)

 

12 (4.8%)

 

Abdominal pain

21 (8.4%)

2 (0.8%)

34 (1.6%)

1 (0.4%)

Abnormal liver function

1 (0.4%)

1 (0.4%)

3 (1.2%)

 

Mucositis/stomatitis

61 (24.4%)

1 (0.4%)

65 (26%)

2 (0.8%)

Sore/bleeding gums

2 (1.6%)

 

8 (3.2%)

 

Epistaxis

6 (2.4%)

 

3 (1.2%)

 

Blepharitis/conjunctivitis

61 (24.4%)

 

60 (24%)

 

Pleuritic chest pain

22 (8.8%)

 

60 (24%)

3 (1.2%)

Shortness of breath

1 (0.4%)

 

5 (2%)

 

Pleural effusion

   

1 (0.4%)

Skin rash

8 (3.2%)

1 (0.4%)

2 (0.8%)

1 (0.4%)

Vaginal bleeding

49 (19.6%)

4 (1.6%)

38 (15.2%)

2 (0.8%)

  1. aIn all, 92 (36.8%) had no toxicity during their first course; 67 (26.8%) had no toxicity during subsequent courses.